Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

RNA Therapeutics


Guillermo Tramontin and Cecilia Piergentili


While traditionally small molecules medicines and antibodies target specific proteins, RNA therapeutics target RNA molecules involved in disease processes, allowing for more precise and effective treatment. 

A key advantage of RNA therapeutics is the ability to target previously "undruggable" targets, such as transcription factors and non-coding RNAs, which are often involved in complex disease pathways. 

Additionally, RNA-based treatments can be designed to be highly selective and specific, reducing the risk of off-target effects and improving safety profiles (Winkler, 2021; Zhu et al. 2022). 

Development of these innovative therapies has been facilitated by technological advances and an understanding of RNA biology, including synthesizing and delivery of RNA molecules to specific tissues and cells in the body. 

Download '.pdf' Format of the whitepaper.

Download Whitepapers
magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinRehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024